Trademark Search  /  ALCHEMAB

ALCHEMAB

● Live · Registered

U.S. federal trademark · Serial No. 79403954 · Reg. No. 8026498

Mark
ALCHEMAB
Status
Registered
Serial Number
79403954
Registration No.
8026498
Filing Date
July 3, 2024
Registration Date
November 18, 2025
Class(es)
Class 005, Class 009, Class 042, Class 044

Owners

Alchemab Therapeutics Ltd
99 · London, GB
Alchemab Therapeutics Ltd
99 · London N1C 4AX, GB
Alchemab Therapeutics Ltd
99 · London N1C 4AX, GB

Goods & Services

Pharmaceutical preparations incorporating antibodies for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; pharmaceutical preparations incorporating antibody technology for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; chemical preparations for medical and pharmaceutical purposes incorporating antibodies for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; Chemical preparations for medical and pharmaceutical purposes incorporating antibody technology for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; antibodies for medical purposes; diagnostic preparations involving the testing and identification of antibodies for medical purposes; diagnostic preparations involving the testing of antibodies for medical purposes; diagnostic preparations involving the identification of antibodies for medical purposes.

Downloadable software for the testing of antibodies; downloadable software for the identification of antibodies; downloadable software for use in development of pharmaceutical preparations incorporating antibodies; downloadable software for use in development of pharmaceutical preparations incorporating antibody technology.

Medical diagnostic services involving the testing of antibodies for medical purposes; medical diagnostic services involving the identification of antibodies for medical purposes; medical testing, analysis and diagnostic services in the field of antibodies; information, advisory and consultancy services in relation to all of the aforesaid.

Research and development services in the field of antibodies and antibody technology; drug development and discovery services in relation to pharmaceutical preparations incorporating antibodies and antibody technology; antibody discovery services in the nature of drug discovery services; development and testing of computing methods, algorithms and software for the testing and identification of antibodies; development and testing of computing methods, algorithms and software in the field of antibody technology; development and testing of computing methods, algorithms and software for use in or relating to the development of pharmaceutical preparations incorporating antibodies and antibody technology; information, advisory and consultancy services in relation to all of the aforesaid.

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ALCHEMAB" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.